GLOW Blend: GHK-Cu, BPC-157 & TB-500 Tissue-Signaling Research Overview
GLOW is a 70mg three-component research blend combining the copper tripeptide GHK-Cu with two signaling peptides, BPC-157 and TB-500. It is used in preclinical work that examines complementary branches of the tissue-remodeling cascade — extracellular-matrix signaling, vascular signaling, and cytoskeletal/cell-migration dynamics — within a single defined material.
In Stock · Ships Same Day
Order GLOW Blend
Lyophilized synthetic reference compound. 7x independently tested. Full Certificate of Analysis with every batch.
What is in the GLOW blend?
GLOW combines three well-characterized research compounds: GHK-Cu, BPC-157, and TB-500. Each is independently synthesized to research-grade purity and verified before combination, so the analytical identity of all three species is documented in the blend.
GHK-Cu: extracellular matrix and copper signaling
GHK-Cu (glycyl-L-histidyl-L-lysine bound to copper) is studied in preclinical models for its effects on dermal fibroblast gene expression, extracellular-matrix remodeling, and copper-dependent signaling.[1][2] It is one of the most extensively characterized copper peptides and serves as a reproducible reference standard for metallopeptide research.
Buy GLOW Blend Research Material
Lab tested · Full COA · Ships same day from US facility
BPC-157 and TB-500: vascular and cytoskeletal signaling
BPC-157, a gastric-derived pentadecapeptide, is examined for VEGFR2 activation and nitric-oxide pathway signaling associated with angiogenesis-related effects in preclinical wound and tissue models.[3] TB-500, the actin-binding fragment of thymosin beta-4, is studied for actin dynamics, cell migration, and downstream angiogenesis signaling.[4] Their reported mechanisms are non-overlapping, which is why they are frequently studied side-by-side.
Rationale for the blend and analytical testing
Combining a matrix/copper-signaling compound with two distinct repair-cascade peptides lets researchers observe potential complementary interactions across the extracellular-matrix, vascular, and cell-migration branches within a single experimental system, while retaining documented purity and identity for each constituent.
Each GLOW batch undergoes the 7-round independent analytical program (HPLC purity, mass spectrometry identity confirmation of each species, endotoxin screening, sterility verification, plus conformity vials), tested by third-party laboratories Kovera Labs and Freedom Diagnostics, with a full Certificate of Analysis for each production lot. For research use only. Not for human or veterinary use; not approved by the FDA for any human therapeutic, diagnostic, or medical purpose.
Ready to order?
Get GLOW Blend Today
Independently lab-tested with a published Certificate of Analysis for every batch. Lyophilized synthetic reference compound, shipped same day from a US facility.
View product detailsCommon Questions
What is GLOW Blend?
Why study these peptides together?
How is product quality verified?
References
- 1.Pickart L, Margolina A. The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline. Brain Sciences. 2017. PMID: 28208679
- 2.Pyo HK, Yoo HG, Won CH, et al. The effect of tripeptide-copper complex on human hair growth in vitro. Archives of Pharmacal Research. 2007. PMID: 17601036
- 3.Hsieh MJ, Liu HT, Wang CN, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of Molecular Medicine. 2017. PMID: 27847966
- 4.Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends in Molecular Medicine. 2005. (Review of thymosin beta-4 actin regulation and tissue-repair signaling.)